UPDATE 2-Fosun Pharma to buy 100 mln doses of BioNTech's COVID-19 vaccine for mainland China Reuters 12/16/2020 (Adds profit breakdown, other supply deals) Dec 16 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd on Wednesday said it will buy at least 100 million doses of a COVID-19 vaccine from Germany's BioNTech SE for use in mainland China next year, if the vaccine receives approval. The Chinese government has not announced supply deals with Western drugmakers, which instead have partnered local firms. Fosun said it will be entitled to 60% of annual gross profit from sales of doses that it will make from imported bulk ingredients, and 65% of profit from sales of doses imported ready for use.